Ardent Health, Inc. reports developments for a healthcare provider serving growing mid-sized urban communities in the United States. Through its subsidiaries, the company operates acute care hospitals and other sites of care across six states, with recurring updates centered on patient volume, admissions, net patient service revenue, adjusted EBITDA, cash flow, guidance, and balance-sheet priorities.
Company news also covers management presentations at healthcare investor conferences, operational-efficiency initiatives such as the IMPACT program, payer and Exchange market dynamics, and technology investments in virtual care. Recent operating updates include enterprise use of AI-assisted virtual nursing, patient observation, and patient-safety monitoring to support clinical workflows across inpatient settings.
Ardent Health (NYSE:ARDT), a healthcare provider focused on mid-sized urban communities across the U.S., has announced its participation in three major healthcare investor conferences in September 2025:
- Wells Fargo Healthcare Conference in Boston (September 4, 8:45 a.m. ET)
- Morgan Stanley Global Healthcare Conference in New York City (September 8, 7:45 a.m. ET)
- Jefferies Healthcare Services Conference in Nashville (September 29, 10:45 a.m. ET)
Management will participate in fireside chats at each event, with live webcasts available on the company's investor relations website. One-on-one meetings with registered investors will also be available.
Ardent Health (NYSE:ARDT) reported strong Q2 2025 financial results with notable growth across key metrics. The company achieved total revenue of $1.65 billion, representing an 11.9% year-over-year increase, and net income of $73 million ($0.52 per diluted share).
Key performance highlights include a 38.9% increase in Adjusted EBITDA to $170 million, 6.6% growth in admissions, and 10.2% growth in net patient service revenue per adjusted admission. The company's lease-adjusted net leverage ratio improved to 2.7x from 3.0x in Q1.
Ardent Health reaffirmed its 2025 guidance with projected total revenue of $6.2-6.45 billion and Adjusted EBITDA of $575-615 million. The company continues to expand its ambulatory care network with plans to open five urgent care centers and two imaging care centers before year-end.
Ardent Health (NYSE:ARDT), a healthcare provider focused on mid-sized urban communities across the U.S., has scheduled its second quarter 2025 earnings release for Tuesday, August 5, 2025, after market close.
The company will host a conference call and webcast on Wednesday, August 6, 2025, at 10 a.m. ET to discuss the results. The webcast and presentation materials will be available on the company's investor relations website. A replay will be accessible through August 20, 2025.
Ardent Health Partners (NYSE: ARDT) announced that its board of directors has approved a corporate name change to Ardent Health, Inc., effective June 3, 2025. The healthcare provider, which operates in growing mid-sized urban communities across the U.S., is aligning its legal name with its commonly used brand identity "Ardent Health". The name change will not affect the company's NYSE trading symbol (ARDT), CUSIP number, or stockholder rights.
Ardent Health (NYSE: ARDT) has appointed Chris Schoeplein as its new chief development officer to spearhead the company's strategic growth initiatives. Schoeplein, who previously served as senior vice president at Kaufman Hall's mergers and acquisitions practice, brings nearly two decades of healthcare strategy and development experience to the role.
In his new position, Schoeplein will be responsible for leading development efforts across Ardent's existing markets and supporting expansion into new regions. His key responsibilities include driving growth in inpatient and outpatient care settings through acquisitions, partnerships, and joint ventures, while also overseeing due diligence, market intelligence, and integration planning.
The appointment comes at what CEO Marty Bonick describes as a "pivotal time" in Ardent's growth journey, as the company aims to scale its consumer-centric platform and extend its joint venture model.Ardent Health (NYSE: ARDT), a healthcare provider focused on mid-sized urban communities across the U.S., has announced its participation in two major investor conferences in May 2025:
- Bank of America Securities 2025 Health Care Conference in Las Vegas (May 13-14), featuring a presentation on May 14 at 11:40 a.m. ET
- 2025 RBC Capital Markets Global Healthcare Conference in New York City (May 20), including a fireside chat at 8:00 a.m. ET
Live audio webcasts will be available on Ardent Health's investor relations website with 90-day replay access. Management will also conduct one-on-one meetings with registered investors at both conferences.
Ardent Health (NYSE: ARDT) has scheduled its first quarter 2025 financial results announcement for Tuesday, May 6, 2025, after market close. The company will host a conference call and webcast on Wednesday, May 7, 2025, at 10:00 a.m. ET to discuss the results and conduct a Q&A session.
The webcast and presentation materials will be accessible through the Investor Relations section at ir.ardenthealth.com. Participants are advised to register 15 minutes before the scheduled start time. The teleconference replay will be available until May 21, 2025.
Ardent Health (NYSE: ARDT) has announced key leadership changes, appointing Dave Caspers as chief operating officer to oversee operations across 30 hospitals and 280 sites of care in six states. Caspers, formerly vice president of omnichannel operations at Walmart Health, brings extensive experience in retail healthcare and health system operations.
The company also announced three senior leadership promotions: Anika Gardenhire elevated to chief digital and transformation officer, Rebecca Kirkham promoted to senior vice president and chief communications and corporate affairs officer, and Reed Smith elevated to senior vice president and chief consumer officer.
In his new role, Caspers will focus on executing strategic growth initiatives, driving operational excellence, and optimizing the company's consumer-centric operating model across markets.